Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Три наблюдения успешной активной (стремящейся к достижению ремиссии) терапии пожилых пациентов с различными ревматическими заболеваниями
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Губарь Е.Е., Бочкова А.Г., Бунчук Н.В. Некоторые аспекты комбинированной базисной терапии ревматоидного артрита. Науч.-практ. ревматол. 2006; 1: 49–55.
2. O'Dell JR, Haire CE, Erikson N et al. Treatment of rheumatoid arthritis with methotrexate alone, sulphasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996; 334: 1287–91.
3. O'Dell JR, Leff R, Paulsen G et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of three medications. Arthrit Rheum 2002; 46: 1164–70.
4. Filippini M, Bazzani C, Zingarelli S et al. Anti-TNFalpha agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients. Reumatismo 2008; 60: 41–9.
5. Migliore A, Bizzi E, Lagang B et al. The safety of anti-TNF agents in the elderly. Int J Immunopathol Pharmacol 2009; 22: 415–26.
6. Rennard SI, Fogarty C, Kelsen S et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 926–34.
7. Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction Arthritis Rheum 1990; 33: 1065–7.
8. Krafcik SS, Covin RB, Lynch JP. Wegener's granulomatosis in the elderly. Chest 1996; 109: 430–7.
9. Faurschou M et al. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol 2008; 35: 100–5.
10. Keogh KA, Ytterberg SR, Fervenza FC. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 2006; 173: 180–7.
11. van Riel CM, Weinblatt ME, Weisman MH et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009. Ann Rheum Dis 2010; 69: i2–i29.
2. O'Dell JR, Haire CE, Erikson N et al. Treatment of rheumatoid arthritis with methotrexate alone, sulphasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996; 334: 1287–91.
3. O'Dell JR, Leff R, Paulsen G et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of three medications. Arthrit Rheum 2002; 46: 1164–70.
4. Filippini M, Bazzani C, Zingarelli S et al. Anti-TNFalpha agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients. Reumatismo 2008; 60: 41–9.
5. Migliore A, Bizzi E, Lagang B et al. The safety of anti-TNF agents in the elderly. Int J Immunopathol Pharmacol 2009; 22: 415–26.
6. Rennard SI, Fogarty C, Kelsen S et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 926–34.
7. Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction Arthritis Rheum 1990; 33: 1065–7.
8. Krafcik SS, Covin RB, Lynch JP. Wegener's granulomatosis in the elderly. Chest 1996; 109: 430–7.
9. Faurschou M et al. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol 2008; 35: 100–5.
10. Keogh KA, Ytterberg SR, Fervenza FC. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 2006; 173: 180–7.
11. van Riel CM, Weinblatt ME, Weisman MH et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009. Ann Rheum Dis 2010; 69: i2–i29.
Авторы
Е.Е.Губарь, А.Г.Бочкова, С.Х.Седышев, В.И.Васильев,О.А.Логвиненко, Н.В.Бунчук
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.